◆ 会议时间：2027年4月15-18日
◆ 会议地点：阿拉伯联合酋长国 迪拜

◆ 会议简介：

2027年国际肾脏病学会(ISN)世界肾脏病大会(ISN WCN 2027)将于2027年4月15-18日在阿拉伯联合酋长国迪拜举行，本次会议由国际肾脏病学会（ISN）组织。世界肾脏病大会(WCN)汇聚了数千名世界肾脏保健领域的顶尖专家，介绍最新的进展，交流最新的科学，讨论最新的临床应用，旨在改善肾脏健康和预防肾脏疾病。本次会议由国际肾脏病学会(ISN)组织，阿根廷肾脏病学会(SAN)、拉丁美洲肾脏病和高血压学会(SLANH)联合举办。

ISN世界肾脏病学大会(WCN)是首屈一指的国际肾脏病学教育活动，原每两年在各大洲间轮流举办一次，由ISN与当地和地区的肾脏病学协会合作举办，自2019年之后改为每年举办一次；大会针对的是国际肾脏病学界以及其他从事多学科肾脏护理的医疗专业人员。WCN使来自世界各地的专业人士能够就与肾脏病学相关的各种主题交换意见，并支持ISN的使命，即建立一个所有人都能公平获得可持续肾脏健康的未来。

国际肾脏病学会（ISN）成立于1960年，是致力于促进全球肾脏健康的慈善组织，现在全球152个国家和地区拥有超过10000名专业成员。ISN的使命是通过教育宣和培训在全球范围内促进可持续性的肾脏健康。ISN代表着广泛的国际交流网络，并为世界各地的医疗保健专业人士间进行及时的科学交流、讨论、传播提供了一个高效的平台。此外ISN还与全球90多个国家与地区的肾脏病学协会密切合作，额外连接着30000余名专业人士。ISN的总体目标是应对急性肾损伤(AKI)、慢性肾脏病(CKD）和终末期肾脏病(ESKD)的全球负担，通过相互关联的宣传、教育和研究策略改善患者护理。ISN还致力于解决发展中国家与发达国家在肾脏病的研究、诊断、治疗和预防方面的差距。ISN通过会员、出版物、会议、项目以及世界肾脏日等形式，努力推动全球肾脏病学的发展。ISN自2019年开始在世界不同的地区举办国际肾脏病学界领先的教育活动——世界肾脏病大会（WCN）。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

World Congress of Nephrology (WCN 2027)

Dates:
April 15–18, 2027

Venue:
Dubai, United Arab Emirates

Organized by :
International Society of Nephrology (ISN)

Co-hosted by：

摘要征文投稿：

Submission opens
June 22, 2026

Submission deadline
October 28, 2026

Notification of acceptance
December 8, 2026

点此提交摘要>>>Submit Abstract>>>

点此查看更多摘要提交相关信息>>>

Abstract instructions and requirements

• Language: English
• Character limit: Up to 3,400 characters, including spaces. This excludes authors’ names, affiliations, keywords, and any tables or graphs inserted as images.
• Structure: Use a structured format with introduction, methods, results, and conclusion sections. Review carefully for typos, misspellings, and errors before submission.
• Co-authors: You may list up to 15 co-authors per abstract.
• Images: Images must be in JPEG or PNG format (maximum 640wx480h pixels, 1.5 MB).
• Case reports that present novel hypotheses, pathologies, treatments, or ethical issues are welcome. However, they are only likely to be selected if the originality is highlighted effectively.
• Encore abstracts: Allowed if permitted by both the initial and subsequent conferences. Authors must disclose this at the end of the abstract: “This abstract was also submitted for the [insert meeting title] congress.“
• Ethical compliance: Research must adhere to the Declaration of Istanbul on Organ Trafficking and Transplant Tourism.
  • By submitting, you confirm that your work complies with ethical principles regarding live donation and research on human subjects.
• Embargo policy: For abstracts accepted for presentation and publication during WCN’27, the embargo policy applies according to your selection during the submission process.
  • Published prior to the congress
  • Published after the embargo is lifted on April 4, 2027 at 12 p.m. MYT.
  • Or, to NOT published

Details about AI technologies usage:

• Generative AI disclosure: If generative AI or AI-assisted technologies were used in the writing process, authors must disclose this during submission and include a statement at the end of the abstract under the heading Declaration of Generative AI and AI-Assisted Technologies in the Writing Process.
• Permitted use of AI: Generative AI and AI-assisted technologies may only be used to improve readability and language. Authors must maintain human oversight and carefully review and edit all content, as AI-generated outputs may be inaccurate, incomplete, or biased.
• Authorship: AI and AI-assisted technologies must not be listed as authors or co-authors, nor cited as authors. Authorship responsibilities can only be attributed to humans, in accordance with the Kidney International Reports® (Elsevier) policy for authors.
• No disclosure required: Disclosure is not required for the use of basic tools solely for grammar, spelling, reference checking, or similar editorial assistance. If there is nothing to disclose, no statement is required.

WCN2027 注册费：

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。